Trials / Conditions / Olverembatinib
Olverembatinib
3 registered clinical trials studyying Olverembatinib — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphi NCT07178912 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment NCT07282093 | Ascentage Pharma Group Inc. | Phase 1 |
| Unknown | Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-gen NCT05311943 | Shenzhen Second People's Hospital | Phase 3 |